儿童肾活检出血并发症的系统评价与荟萃分析
结果显示血肿发生比例在11%至18%之间,需输血比例为0.9%,需额外干预比例为0.7%。实时超声引导及活检类型(原生肾 vs 移植肾)均未显著改变上述风险。
要点
- 儿童肾活检后肾周血肿并不少见,发生比例约11%至18%。
- 需输血或额外干预的比例较低,分别为0.9%和0.7%。
- 实时超声引导未显著降低血肿、输血或额外干预风险。
核心结论
- 儿童肾活检后肾周血肿发生并不罕见,但需输血或额外干预的比例显著较低。
主要发现
- 血肿发生比例在11%(95%CI 7%至17%)至18%(95%CI 9%至35%)之间,取决于不同时间窗分析。
- 需输血比例为0.9%(95%CI 0.5%至1.4%)。
- 需额外干预比例为0.7%(95%CI 0.4%至1.1%)。
- 荟萃回归显示实时超声引导未改变血肿、输血或额外干预风险。
- 原生肾活检与移植肾活检在需输血或额外干预方面无显著差异。
临床怎么用
- 儿童肾活检前应告知血肿发生风险较高,但严重出血并发症风险较低。
- 实时超声引导虽未显示降低出血风险,但仍需结合临床具体情况决策。
局限性
- 原始文献缺乏实验室值、针规格、穿刺次数、患者年龄及操作者(主治 vs 培训者)数据,无法进行二次分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Kidney biopsy is an essential tool for the diagnosis and treatment of patients with kidney disease; however, because of its invasive nature, bleeding complications may arise. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a meta-analysis of prospective or retrospective observational studies and randomized, controlled trials in pediatric patients undergoing native or transplant kidney biopsy in an inpatient or outpatient setting in MEDLINE-indexed studies from January 1998 to November 1, 2017 to determine the proportion of patients who develop hematoma, need blood transfusion, or need an additional intervention due to a complication after kidney biopsy. RESULTS: Twenty-three studies of 5504 biopsies met inclusion criteria. The proportion of patients developing hematoma after biopsy was between 11% (95% confidence interval, 7% to 17%) and 18% (95% confidence interval, 9% to 35%) using two analyses that included different time periods. The proportion needing blood transfusion was 0.9% (95% confidence interval, 0.5% to 1.4%). The proportion needing an additional intervention due to postbiopsy complication was 0.7% (95% confidence interval, 0.4% to 1.1%). Secondary analysis was not possible due to lack of data in the original manuscripts on laboratory values, needle gauges, number of needle passes, age of patient, or performer (attending versus trainee). Analysis with metaregression found that use of real-time ultrasound during biopsy did not modify the risk for hematoma, requirement of a blood products transfusion, or requirement of an additional procedure after biopsy. Analysis with metaregression comparing native biopsies with transplant biopsies did not reveal that biopsy type (native kidney biopsy versus transplant kidney biopsy) was associated with the need for a blood transfusion or requirement of an additional intervention after biopsy. CONCLUSIONS: The development of perinephric hematoma after kidney biopsy is not an infrequent finding. The proportion of patients requiring blood transfusion or needing an additional intervention as a result of kidney biopsy in pediatric patients is significantly smaller.
引用
- Varnell CD, Stone HK, Welge JA, et al. Bleeding Complications after Pediatric Kidney Biopsy: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2018. PMID: 30522995. doi:10.2215/CJN.05890518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。